Volume increases in putamen associated with positive symptom reduction in previously drug-naive schizophrenia after 6 weeks antipsychotic treatment.
about
Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortiumGenome-wide association study of paliperidone efficacySimilar and different gray matter deficits in schizophrenia patients and their unaffected biological relativesA multi-scanner study of subcortical brain volume abnormalities in schizophrenia.The polymorphism of YWHAE, a gene encoding 14-3-3epsilon, and brain morphology in schizophrenia: a voxel-based morphometric studyImaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA.Larger putamen size in antipsychotic-naïve individuals with schizotypal personality disorder.Basal ganglia volume in unmedicated patients with schizophrenia is associated with treatment response to antipsychotic medication.Optimizing outcomes in schizophrenia: long-acting depots and long-term treatment.Decreased Left Putamen and Thalamus Volume Correlates with Delusions in First-Episode Schizophrenia Patients.First- and second-generation antipsychotic drug treatment and subcortical brain morphology in schizophrenia.Classification of multi-site MR images in the presence of heterogeneity using multi-task learning☆.A Perspective of the Cross-Tissue Interplay of Genetics, Epigenetics, and Transcriptomics, and Their Relation to Brain Based Phenotypes in Schizophrenia
P2860
Q23747506-7B8EEF94-D0E8-4786-9BBF-C0F1003A6BFBQ28587963-A332E7FE-5A9B-4B8C-82CE-A0EA6E1D4E6DQ30711211-7DB9F5DA-9576-4F61-8139-907C666B8398Q33761026-07C64CE9-3FBA-4B34-8848-95F22BEDEDC6Q34020393-5721D271-05F2-41B0-BF4F-40FB88251CAEQ34701163-8A617D80-577F-4D8D-A9C2-3CDAA22B335BQ36790073-C1BE78B2-E0C2-41E3-B9BF-8B423777CDCCQ37627386-FD058E51-B3E2-435C-AFDA-5424557FFAC2Q38086645-E8B1CAE0-A73A-4DC7-9F98-BC14B4725FA5Q47142790-250CDE58-D653-42A5-B961-46594755C208Q50556051-1996EB88-99BA-4B0E-905F-1746B17C5E91Q55437545-628B51BB-A3C2-417C-9787-1B6E2729219BQ58712902-A066E1CA-197F-4BA4-BBC2-BE4D6E546F29
P2860
Volume increases in putamen associated with positive symptom reduction in previously drug-naive schizophrenia after 6 weeks antipsychotic treatment.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Volume increases in putamen as ...... weeks antipsychotic treatment.
@en
Volume increases in putamen as ...... weeks antipsychotic treatment.
@nl
type
label
Volume increases in putamen as ...... weeks antipsychotic treatment.
@en
Volume increases in putamen as ...... weeks antipsychotic treatment.
@nl
prefLabel
Volume increases in putamen as ...... weeks antipsychotic treatment.
@en
Volume increases in putamen as ...... weeks antipsychotic treatment.
@nl
P2093
P2860
P1476
Volume increases in putamen as ...... weeks antipsychotic treatment
@en
P2093
P2860
P304
P356
10.1017/S0033291711002157
P407
P577
2011-10-26T00:00:00Z